Virginia Bio Names John Newby CEO
Virginia Bio announces John Newby will become CEO of Virginia Bio starting August 5, 2019. John will be stepping down as Commissioner of the Virginia Department of Veterans Services, where for the last 7 years he led this 800-member Agency located across more than 40...
Webster Santos – VT and Kevin Lynch-UVA received a $2.8 NIAID grant to Develop a Drug to Treat Multiple Sclerosis
Santos received this research grant in collaboration with Kevin Lynch, a professor of pharmacology at the University of Virginia. Lynch will oversee the biological testing of the drug. The NIAID award builds on an existing research grant from the National Institute of...
NIH Provides $23 million for Statewide Translational Research Institute
The integrated Translational Health Research Institute of Virginia (iTHRIV) has been awarded a five-year grant of nearly $23 million from the National Institutes of Health (NIH) to advance innovative ideas from the point of discovery to implementation in clinical...
Dr. Umesh Desai, VCU, is Awarded a 5 year Grant
The Desai lab has received the “Glycans in Blood Homeostasis and Disease” grant. This is a five-year K12 grant by National Heart, Lung and Blood Institute to train MDs, PhDs and dual degree holders for advanced careers in glycosciences. Only four such K12 grants were...
Center for Molecular Imaging – VCU Supports Research Virginia-wide
Dr. Jamal Zweit, Director for the Molecular Imaging Center writes- About the Center for Molecular Imaging at VCU: The Center for Molecular Imaging (CMI) at VCU conducts multidisciplinary molecular imaging research using non-invasive imaging technologies. The...
Virginia Tech Center for Drug Discovery Researcher receives $1.2 million to find Compounds to Treat Fatty Liver Disease
Webster Santos (VT), Kyle Hoehn (UVA): A grant from the VBHRC, known as Virginia Catalyst along with matching funds from Continuum Biosciences, a company they co-founded will fund research to fight a liver condition that can lead to liver cancer. Read more ...
Frank Gupton receives a $25M award from the Gates foundation
Frank Gupton receives a $25M award from the Gates foundation for the "Medicines for All" Initiative" The Bill & Melinda Gates Foundation has awarded the Virginia Commonwealth University School of Engineering $25 million to create the Medicines for All Institute, a...
VirginiaCancerRx in the News!
John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...
Award-winning “intrapreneur” researcher Rob Gourdie launches Acomhal Research Inc.
Professor Rob Gourdie, Director of the Virginia Tech Carilion Research Institute’s (VTCRI) Center for Heart and Regenerative Medicine Research, previously founded First String Research Inc., which is poised to commercialize a treatment for debilitating foot ulcers in...
Carlier & Slade receive grant to develop new malaria therapeutics
A team headed by Paul Carlier, Professor of Chemistry, Virginia Tech has received funding from the National Institutes of Health to carry out lead optimization on antimalarial drug candidate MMV008138. Carlier, who is Deputy Director of the Virginia Tech Center for...